Back to 
Point72 Asset Management, L.P.
Point72 Asset Management, L.P.
FULC
Showing 5 of 21 quarters
Position history for Point72 Asset Management, L.P.'s holdings in Fulcrum Therapeutics, Inc.
Yes. Point72 Asset Management holds 651,427 shares of FULC (Fulcrum Therapeutics), worth $2.4M, as of its Q2 2026 13F filing. It reduced the position by 1,423,428 shares (-68.6%) from Q1 2026. Point72 Asset Management has held FULC since Q4 2025, across 3 quarterly 13F filings.
Current Value
$2.4M
Current Shares
651,427
Total Value Change
-$1M
Total Shares Change
+153,208
Quarter-by-Quarter History